Novo Nordisk saw a competitor’s bet and raised the stakes in metabolic dysfunction-associated steatohepatitis (MASH) with its planned up-to-$5.2 billion acquisition of Akero Therapeutics.

Programmable proteins designed with Boolean logic gates may improve targeted drug delivery precision and scalability, ...

During GEN's State of Biotech virtual summit, George Church, PhD, shared his thoughts on genomics and much, much more.

Raubling, Germany-based Axplora, which focuses on small-molecule API manufacturing reports that its total investments ...

The ASHG president offers some meeting highlights and what she will be looking forward to next week in Boston.

Universities must do more to provide students with cell and gene therapy manufacturing skills, according to a new study.

The super adjuvant vaccine also protected against the spread of cancer to the lungs. When exposed to melanoma cells systemically, which mimics how cancer metastasizes, none of the ...

The largest genetic map of human metabolism reveals new insights on the role of metabolites in health and disease.

Longitudinal GBM biopsies uncovered effects of immunotherapy that could not be surmised by routine MRI or clinical analyses.

Researchers in China have determined to identify the genetic basis for the naked mole-rats’ increased longevity.

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

Izpisua Belmonte, PhD, Altos Labs, advocates a disease-agnostic approach, but first, he said, “we must understand the mechanism, something that is core to the cell.” ...